Elizabeth currently focuses on creating new tissue models for safety and efficacy evaluation, as well as developing studies and tools in clinical biology. She joined the CRC after moving back to California from L’Oreal Singapore, where she established collaborations with research institutes on a variety of topics, ranging from skin stem cells to microparticles for encapsulating active ingredients.

Prior to L'Oreal, Elizabeth worked on developing self-assembling peptide hydrogels for cell scaffolds as a postdoctoral research fellow at the Institute of Bioengineering and Nanotechnology in Singapore. She has a B.S. in Bioengineering from UC Berkeley and a Ph.D. in Bionengineering from UC San Diego, where her thesis work focused on the development of nanostructured materials for sustained ocular drug delivery.